Epigenetic drivers of metalloproteinases and metastasis
Trends in Cell Biology · 2025-12 · 35 (12) · 1054-1067
DOI: 10.1016/j.tcb.2025.02.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cell Biology, 2025-12. Verfasst von Marco Seehawer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA…. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Neoplasm Metastasis, Metalloproteases, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Novartis, National Institutes of Health National Cancer Institute.
Abstract (Originalsprache)
Metalloproteinases (MPs) are crucial for development and homeostasis due to their diverse physiological functions, from the cellular to the organismal level. Their activity is tightly regulated at multiple levels, including epigenetic regulation through DNA methylation and histone modifications. Aberrant MP expression can result in pathological events, involving extracellular matrix remodeling, which can facilitate cancer cell invasion and dissemination. As clinical testing of MP inhibitors has been limited by toxicity, alternative approaches are needed. Epigenetically-driven MP expression is often specific to cancer cells, giving an enticing possibility for cancer cell-specific targeting. Moreover, aberrant epigenetic activity can also drive other metastatic events. Therefore, targeting the epigenetic regulators of MP expression may be a promising alternative approach for the prevention and treatment of metastatic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, M…
Förderung
- NCI NIH HHS
- Novartis
- National Institutes of Health National Cancer Institute
Zitieren
APA
Seehawer, M., & Polyak, K. (2025). Epigenetic drivers of metalloproteinases and metastasis. Trends in Cell Biology, 35(12), 1054-1067. https://doi.org/10.1016/j.tcb.2025.02.010
Vancouver
Seehawer M, Polyak K. Epigenetic drivers of metalloproteinases and metastasis. Trends in Cell Biology. 2025;35(12):1054-1067. doi:10.1016/j.tcb.2025.02.010
BibTeX
@article{Seehawer2025,
author = {Seehawer, Marco and Polyak, Kornelia},
title = {Epigenetic drivers of metalloproteinases and metastasis},
journal = {Trends in Cell Biology},
year = {2025},
volume = {35},
number = {12},
pages = {1054--1067},
doi = {10.1016/j.tcb.2025.02.010}
}
EUVIMED